| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-cysteine S-palmitoyltransferase activity | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 3.52e-16 | 26 | 43 | 8 | GO:0019706 |
| GeneOntologyMolecularFunction | protein-cysteine S-acyltransferase activity | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 3.52e-16 | 26 | 43 | 8 | GO:0019707 |
| GeneOntologyMolecularFunction | S-acyltransferase activity | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 1.31e-15 | 30 | 43 | 8 | GO:0016417 |
| GeneOntologyMolecularFunction | palmitoyltransferase activity | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 8.55e-15 | 37 | 43 | 8 | GO:0016409 |
| GeneOntologyMolecularFunction | protein-cysteine S-myristoyltransferase activity | 2.18e-13 | 6 | 43 | 5 | GO:0019705 | |
| GeneOntologyMolecularFunction | protein-cysteine S-stearoyltransferase activity | 7.62e-13 | 7 | 43 | 5 | GO:0140439 | |
| GeneOntologyMolecularFunction | myristoyltransferase activity | 1.67e-11 | 11 | 43 | 5 | GO:0019107 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 3.66e-08 | 238 | 43 | 8 | GO:0016747 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.69e-07 | 26 | 43 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium ion binding | 3.33e-06 | 14 | 43 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.68e-06 | 52 | 43 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | folic acid receptor activity | 1.36e-05 | 3 | 43 | 2 | GO:0061714 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.34e-05 | 26 | 43 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | acyltransferase activity | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 RNF31 ZDHHC3 ZDHHC16 | 3.28e-05 | 775 | 43 | 9 | GO:0016746 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.94e-04 | 171 | 43 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 8.12e-04 | 85 | 43 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | folic acid binding | 8.40e-04 | 20 | 43 | 2 | GO:0005542 | |
| GeneOntologyBiologicalProcess | protein palmitoylation | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 2.39e-15 | 33 | 43 | 8 | GO:0018345 |
| GeneOntologyBiologicalProcess | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 3.45e-14 | 24 | 43 | 7 | GO:0018231 | |
| GeneOntologyBiologicalProcess | peptidyl-L-cysteine S-palmitoylation | 3.45e-14 | 24 | 43 | 7 | GO:0018230 | |
| GeneOntologyBiologicalProcess | protein targeting to membrane | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 FYN ZDHHC3 FOLR1 FOLR3 | 4.46e-13 | 149 | 43 | 10 | GO:0006612 |
| GeneOntologyBiologicalProcess | peptidyl-cysteine modification | 9.57e-12 | 50 | 43 | 7 | GO:0018198 | |
| GeneOntologyBiologicalProcess | protein lipidation | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 3.14e-11 | 101 | 43 | 8 | GO:0006497 |
| GeneOntologyBiologicalProcess | lipoprotein biosynthetic process | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 4.65e-11 | 106 | 43 | 8 | GO:0042158 |
| GeneOntologyBiologicalProcess | protein acylation | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 5.41e-11 | 108 | 43 | 8 | GO:0043543 |
| GeneOntologyBiologicalProcess | protein targeting | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 RNF31 FYN ZDHHC3 FOLR1 FOLR3 | 2.00e-10 | 373 | 43 | 11 | GO:0006605 |
| GeneOntologyBiologicalProcess | lipoprotein metabolic process | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 6.45e-10 | 147 | 43 | 8 | GO:0042157 |
| GeneOntologyBiologicalProcess | establishment of protein localization to membrane | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 FYN ZDHHC3 FOLR1 FOLR3 | 8.30e-10 | 319 | 43 | 10 | GO:0090150 |
| GeneOntologyBiologicalProcess | protein localization to membrane | WDR19 ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 FYN ZDHHC3 FOLR1 FOLR3 | 1.46e-07 | 705 | 43 | 11 | GO:0072657 |
| GeneOntologyBiologicalProcess | localization within membrane | WDR19 ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 FYN ZDHHC3 FOLR1 FOLR3 | 5.02e-07 | 798 | 43 | 11 | GO:0051668 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 9.19e-07 | 36 | 43 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | folic acid transport | 1.38e-06 | 11 | 43 | 3 | GO:0015884 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | WDR19 LRP2 TARDBP ZDHHC15 NF1 RNF31 ATRX FYN ZDHHC3 FOLR1 FOLR3 TAX1BP1 | 1.51e-06 | 1091 | 43 | 12 | GO:0033365 |
| GeneOntologyBiologicalProcess | forebrain development | 6.59e-06 | 489 | 43 | 8 | GO:0030900 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 8.36e-06 | 62 | 43 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 8.92e-06 | 63 | 43 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 3.21e-05 | 87 | 43 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 4.18e-05 | 93 | 43 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | myelination | 6.69e-05 | 206 | 43 | 5 | GO:0042552 | |
| GeneOntologyBiologicalProcess | axon ensheathment | 7.17e-05 | 209 | 43 | 5 | GO:0008366 | |
| GeneOntologyBiologicalProcess | ensheathment of neurons | 7.17e-05 | 209 | 43 | 5 | GO:0007272 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | 8.59e-05 | 515 | 43 | 7 | GO:0072594 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 8.63e-05 | 112 | 43 | 4 | GO:0019226 | |
| GeneOntologyBiologicalProcess | modified amino acid transport | 1.05e-04 | 44 | 43 | 3 | GO:0072337 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, GABAergic | 1.13e-04 | 45 | 43 | 3 | GO:0032228 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 1.13e-04 | 120 | 43 | 4 | GO:0006835 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.17e-04 | 121 | 43 | 4 | GO:0051899 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.40e-04 | 127 | 43 | 4 | GO:0070252 | |
| GeneOntologyBiologicalProcess | regulation of translational termination | 1.51e-04 | 9 | 43 | 2 | GO:0006449 | |
| GeneOntologyBiologicalProcess | vitamin transport | 2.17e-04 | 56 | 43 | 3 | GO:0051180 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 2.53e-04 | 148 | 43 | 4 | GO:1902414 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.87e-04 | 153 | 43 | 4 | GO:0030048 | |
| GeneOntologyBiologicalProcess | brain development | 3.47e-04 | 859 | 43 | 8 | GO:0007420 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 4.00e-04 | 167 | 43 | 4 | GO:0060048 | |
| GeneOntologyBiologicalProcess | heart process | 4.41e-04 | 309 | 43 | 5 | GO:0003015 | |
| GeneOntologyBiologicalProcess | innate immune response-activating signaling pathway | 4.61e-04 | 312 | 43 | 5 | GO:0002758 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 4.68e-04 | 313 | 43 | 5 | GO:0099173 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 4.93e-04 | 74 | 43 | 3 | GO:0051932 | |
| GeneOntologyBiologicalProcess | head development | 5.45e-04 | 919 | 43 | 8 | GO:0060322 | |
| GeneOntologyBiologicalProcess | translational termination | 5.66e-04 | 17 | 43 | 2 | GO:0006415 | |
| GeneOntologyBiologicalProcess | telencephalon development | 6.11e-04 | 332 | 43 | 5 | GO:0021537 | |
| GeneOntologyBiologicalProcess | activation of innate immune response | 6.19e-04 | 333 | 43 | 5 | GO:0002218 | |
| GeneOntologyBiologicalProcess | circulatory system process | 7.35e-04 | 733 | 43 | 7 | GO:0003013 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, GABAergic | 7.88e-04 | 20 | 43 | 2 | GO:0032230 | |
| GeneOntologyBiologicalProcess | action potential | 8.02e-04 | 201 | 43 | 4 | GO:0001508 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | 8.09e-04 | 976 | 43 | 8 | GO:0018193 | |
| GeneOntologyBiologicalProcess | neural tube development | 8.17e-04 | 202 | 43 | 4 | GO:0021915 | |
| GeneOntologyBiologicalProcess | post-translational protein targeting to endoplasmic reticulum membrane | 8.69e-04 | 21 | 43 | 2 | GO:0006620 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 9.11e-04 | 208 | 43 | 4 | GO:0035725 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 9.31e-04 | 92 | 43 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | immune response-activating signaling pathway | 9.48e-04 | 553 | 43 | 6 | GO:0002757 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 1.04e-03 | 23 | 43 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 1.04e-03 | 23 | 43 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 1.04e-03 | 23 | 43 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.07e-03 | 217 | 43 | 4 | GO:0006941 | |
| GeneOntologyBiologicalProcess | transcytosis | 1.14e-03 | 24 | 43 | 2 | GO:0045056 | |
| GeneOntologyBiologicalProcess | Sertoli cell development | 1.14e-03 | 24 | 43 | 2 | GO:0060009 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response | 1.31e-03 | 589 | 43 | 6 | GO:0031349 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 1.39e-03 | 233 | 43 | 4 | GO:0050806 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.40e-03 | 400 | 43 | 5 | GO:0006936 | |
| GeneOntologyBiologicalProcess | innate immune response activating cell surface receptor signaling pathway | 1.44e-03 | 107 | 43 | 3 | GO:0002220 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 1.45e-03 | 403 | 43 | 5 | GO:1904951 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 1.50e-03 | 238 | 43 | 4 | GO:0050954 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | 1.63e-03 | 615 | 43 | 6 | GO:0002764 | |
| GeneOntologyBiologicalProcess | lipoprotein localization | 1.66e-03 | 29 | 43 | 2 | GO:0044872 | |
| GeneOntologyBiologicalProcess | synaptic vesicle maturation | 1.66e-03 | 29 | 43 | 2 | GO:0016188 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 1.67e-03 | 416 | 43 | 5 | GO:0030522 | |
| GeneOntologyBiologicalProcess | positive regulation of innate immune response | 1.74e-03 | 420 | 43 | 5 | GO:0045089 | |
| GeneOntologyBiologicalProcess | activation of immune response | 1.75e-03 | 623 | 43 | 6 | GO:0002253 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 1.77e-03 | 115 | 43 | 3 | GO:0035418 | |
| GeneOntologyBiologicalProcess | regulation of response to biotic stimulus | 2.05e-03 | 643 | 43 | 6 | GO:0002831 | |
| GeneOntologyBiologicalProcess | fusion of sperm to egg plasma membrane involved in single fertilization | 2.15e-03 | 33 | 43 | 2 | GO:0007342 | |
| GeneOntologyBiologicalProcess | Sertoli cell differentiation | 2.15e-03 | 33 | 43 | 2 | GO:0060008 | |
| GeneOntologyBiologicalProcess | positive regulation of response to biotic stimulus | 2.37e-03 | 451 | 43 | 5 | GO:0002833 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 2.39e-03 | 663 | 43 | 6 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 2.41e-03 | 664 | 43 | 6 | GO:0099177 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic pattern recognition receptor signaling pathway | 2.46e-03 | 129 | 43 | 3 | GO:0039531 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.54e-03 | 275 | 43 | 4 | GO:0006814 | |
| GeneOntologyBiologicalProcess | heart formation | 2.56e-03 | 36 | 43 | 2 | GO:0060914 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | 2.59e-03 | 674 | 43 | 6 | GO:0070201 | |
| GeneOntologyBiologicalProcess | artery development | 2.68e-03 | 133 | 43 | 3 | GO:0060840 | |
| GeneOntologyBiologicalProcess | plasma membrane fusion | 2.70e-03 | 37 | 43 | 2 | GO:0045026 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 2.79e-03 | 135 | 43 | 3 | GO:2000177 | |
| GeneOntologyBiologicalProcess | synapse organization | 2.81e-03 | 685 | 43 | 6 | GO:0050808 | |
| GeneOntologyBiologicalProcess | central nervous system development | 2.96e-03 | 1197 | 43 | 8 | GO:0007417 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.62e-08 | 17 | 43 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 3.55e-07 | 29 | 43 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | Golgi membrane | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 FNDC3A ZDHHC15 ZDHHC12 ZDHHC3 FOLR1 DOP1A | 1.53e-06 | 721 | 43 | 10 | GO:0000139 |
| GeneOntologyCellularComponent | postsynaptic density | 3.02e-04 | 451 | 43 | 6 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 4.08e-04 | 477 | 43 | 6 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 5.39e-04 | 503 | 43 | 6 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 6.62e-04 | 523 | 43 | 6 | GO:0098984 | |
| GeneOntologyCellularComponent | node of Ranvier | 7.67e-04 | 20 | 43 | 2 | GO:0033268 | |
| GeneOntologyCellularComponent | cation channel complex | 1.36e-03 | 235 | 43 | 4 | GO:0034703 | |
| GeneOntologyCellularComponent | axon initial segment | 1.62e-03 | 29 | 43 | 2 | GO:0043194 | |
| HumanPheno | Complex febrile seizure | 1.39e-05 | 16 | 16 | 3 | HP:0011172 | |
| HumanPheno | Pes valgus | 2.16e-05 | 56 | 16 | 4 | HP:0008081 | |
| HumanPheno | Focal hemiclonic seizure | 5.61e-05 | 25 | 16 | 3 | HP:0006813 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 9.20e-05 | 5 | 16 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 9.20e-05 | 5 | 16 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 9.20e-05 | 5 | 16 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 9.20e-05 | 5 | 16 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 9.20e-05 | 5 | 16 | 2 | HP:0032906 | |
| HumanPheno | Normal interictal EEG | 1.38e-04 | 6 | 16 | 2 | HP:0002372 | |
| HumanPheno | Generalized clonic seizure | 1.43e-04 | 34 | 16 | 3 | HP:0011169 | |
| HumanPheno | Dermatological manifestations of systemic disorders | 1.83e-04 | 435 | 16 | 7 | HP:0001005 | |
| HumanPheno | Eyelid myoclonia seizure | 1.92e-04 | 7 | 16 | 2 | HP:0032678 | |
| HumanPheno | Decreased proportion of memory T cells | 1.92e-04 | 7 | 16 | 2 | HP:0032183 | |
| HumanPheno | Photosensitive myoclonic seizure | 2.56e-04 | 8 | 16 | 2 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 2.56e-04 | 8 | 16 | 2 | HP:0200048 | |
| HumanPheno | Reduced impulse control | 2.70e-04 | 1032 | 16 | 10 | HP:5200045 | |
| HumanPheno | Focal clonic seizure | 2.71e-04 | 42 | 16 | 3 | HP:0002266 | |
| HumanPheno | Abnormal proportion of memory T cells | 3.29e-04 | 9 | 16 | 2 | HP:0032182 | |
| HumanPheno | Flushing | 3.79e-04 | 47 | 16 | 3 | HP:0031284 | |
| HumanPheno | Abnormal atrioventricular valve physiology | 3.81e-04 | 215 | 16 | 5 | HP:0031650 | |
| HumanPheno | Cyanosis | 3.89e-04 | 117 | 16 | 4 | HP:0000961 | |
| HumanPheno | Weak cry | 4.29e-04 | 49 | 16 | 3 | HP:0001612 | |
| HumanPheno | Neonatal seizure | 5.00e-04 | 11 | 16 | 2 | HP:0032807 | |
| HumanPheno | Limited neck range of motion | 5.00e-04 | 11 | 16 | 2 | HP:0000466 | |
| HumanPheno | Bilateral tonic-clonic seizure with focal onset | 5.12e-04 | 52 | 16 | 3 | HP:0007334 | |
| HumanPheno | Renal hypoplasia/aplasia | 5.13e-04 | 359 | 16 | 6 | HP:0008678 | |
| HumanPheno | Focal impaired awareness seizure | 5.16e-04 | 126 | 16 | 4 | HP:0002384 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 5.86e-04 | 368 | 16 | 6 | HP:0031432 | |
| HumanPheno | Focal motor seizure | 5.98e-04 | 131 | 16 | 4 | HP:0011153 | |
| HumanPheno | Epilepsia partialis continua | 5.99e-04 | 12 | 16 | 2 | HP:0012847 | |
| HumanPheno | Focal automatism seizure | 5.99e-04 | 12 | 16 | 2 | HP:0032898 | |
| HumanPheno | Perseverative thought | 6.68e-04 | 377 | 16 | 6 | HP:0030223 | |
| HumanPheno | Abnormal nervous system electrophysiology | 6.89e-04 | 924 | 16 | 9 | HP:0001311 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 7.07e-04 | 13 | 16 | 2 | HP:0007058 | |
| HumanPheno | Disordered formal thought process | 7.58e-04 | 386 | 16 | 6 | HP:0025769 | |
| HumanPheno | Abnormal nasal tip morphology | 7.58e-04 | 386 | 16 | 6 | HP:0000436 | |
| HumanPheno | Visual impairment | 8.17e-04 | 1174 | 16 | 10 | HP:0000505 | |
| HumanPheno | Abnormal cry | 8.19e-04 | 61 | 16 | 3 | HP:0025429 | |
| HumanPheno | Slanting of the palpebral fissure | 8.25e-04 | 739 | 16 | 8 | HP:0200006 | |
| HumanPheno | Bilateral tonic-clonic seizure | 8.45e-04 | 394 | 16 | 6 | HP:0002069 | |
| HumanPheno | Abnormality of the abdominal wall | 8.78e-04 | 560 | 16 | 7 | HP:0004298 | |
| HumanPheno | Generalized tonic seizure | 9.43e-04 | 64 | 16 | 3 | HP:0010818 | |
| HumanPheno | Facial tics | 9.48e-04 | 15 | 16 | 2 | HP:0011468 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 9.48e-04 | 15 | 16 | 2 | HP:0007207 | |
| HumanPheno | Abnormal thought pattern | 9.66e-04 | 404 | 16 | 6 | HP:5200269 | |
| HumanPheno | Impulsivity | 9.72e-04 | 149 | 16 | 4 | HP:0100710 | |
| Domain | zf-DHHC | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 1.89e-16 | 23 | 43 | 8 | PF01529 |
| Domain | DHHC | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 4.16e-16 | 25 | 43 | 8 | PS50216 |
| Domain | Znf_DHHC_palmitoyltrfase | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 4.16e-16 | 25 | 43 | 8 | IPR001594 |
| Domain | Na_channel_asu | 5.06e-09 | 10 | 43 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 5.06e-09 | 10 | 43 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 5.06e-09 | 10 | 43 | 4 | PF06512 | |
| Domain | Na_trans_cytopl | 2.26e-07 | 6 | 43 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 2.26e-07 | 6 | 43 | 3 | IPR024583 | |
| Domain | Channel_four-helix_dom | 8.80e-06 | 57 | 43 | 4 | IPR027359 | |
| Domain | - | 8.80e-06 | 57 | 43 | 4 | 1.20.120.350 | |
| Domain | IQ | 3.56e-05 | 81 | 43 | 4 | SM00015 | |
| Domain | Folate_rcpt | 5.15e-05 | 5 | 43 | 2 | IPR004269 | |
| Domain | IQ_motif_EF-hand-BS | 5.39e-05 | 90 | 43 | 4 | IPR000048 | |
| Domain | IQ | 6.13e-05 | 93 | 43 | 4 | PS50096 | |
| Domain | Ion_trans_dom | 1.35e-04 | 114 | 43 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.35e-04 | 114 | 43 | 4 | PF00520 | |
| Domain | Folate_rcpt-like | 1.44e-04 | 8 | 43 | 2 | IPR018143 | |
| Domain | Folate_rec | 1.44e-04 | 8 | 43 | 2 | PF03024 | |
| Domain | IQ | 5.83e-04 | 71 | 43 | 3 | PF00612 | |
| Domain | Ephrin_rec_like | 1.50e-03 | 25 | 43 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.50e-03 | 25 | 43 | 2 | IPR011641 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 8.47e-07 | 31 | 34 | 4 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 9.67e-07 | 32 | 34 | 4 | M27455 | |
| Pathway | REACTOME_MATURATION_OF_SPIKE_PROTEIN | 9.42e-05 | 37 | 34 | 3 | M41728 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.96e-04 | 121 | 34 | 4 | M872 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.58e-04 | 130 | 34 | 4 | M27454 | |
| Pathway | REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS | 3.43e-04 | 57 | 34 | 3 | M41730 | |
| Pathway | REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS | 6.28e-04 | 70 | 34 | 3 | M46438 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 8.43e-04 | 18 | 34 | 2 | MM15023 | |
| Pubmed | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 3.49e-20 | 16 | 43 | 8 | 23034182 | |
| Pubmed | 2.02e-16 | 20 | 43 | 7 | 16647879 | ||
| Pubmed | Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle formation. | 1.01e-11 | 5 | 43 | 4 | 39287388 | |
| Pubmed | 1.01e-11 | 5 | 43 | 4 | 28167757 | ||
| Pubmed | 1.39e-11 | 17 | 43 | 5 | 15603741 | ||
| Pubmed | 2.54e-10 | 9 | 43 | 4 | 16382098 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 34428449 | ||
| Pubmed | The gamma2 subunit of GABA(A) receptors is a substrate for palmitoylation by GODZ. | 7.04e-09 | 4 | 43 | 3 | 15229235 | |
| Pubmed | Palmitoylation and membrane interactions of the neuroprotective chaperone cysteine-string protein. | 1.76e-08 | 5 | 43 | 3 | 18596047 | |
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 17724025 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 3.51e-08 | 6 | 43 | 3 | 23652591 | |
| Pubmed | ZDHHC2 ZDHHC21 ZMYM2 JMJD4 ZDHHC7 ZDHHC20 ZDHHC12 ZNF236 ZDHHC3 ZDHHC16 | 4.15e-08 | 808 | 43 | 10 | 20412781 | |
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 15746173 | ||
| Pubmed | 4.99e-07 | 13 | 43 | 3 | 15123669 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 18079277 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 35348308 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 15760941 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 23793055 | ||
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 1.49e-06 | 2 | 43 | 2 | 17805013 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 27875292 | ||
| Pubmed | Megalin (gp330): a putative endocytic receptor for thyroglobulin (Tg). | 1.49e-06 | 2 | 43 | 2 | 9492085 | |
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 1.49e-06 | 2 | 43 | 2 | 27174182 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 18601978 | ||
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 1.49e-06 | 2 | 43 | 2 | 19465131 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 29790812 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 10498895 | ||
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 1.49e-06 | 2 | 43 | 2 | 23735284 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 19284629 | ||
| Pubmed | Aph2, a protein with a zf-DHHC motif, interacts with c-Abl and has pro-apoptotic activity. | 4.48e-06 | 3 | 43 | 2 | 12021275 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 8304978 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 1894617 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 9166787 | ||
| Pubmed | DHHC7 Palmitoylates Glucose Transporter 4 (Glut4) and Regulates Glut4 Membrane Translocation. | 4.48e-06 | 3 | 43 | 2 | 28057756 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 32845893 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 16033895 | ||
| Pubmed | Role of sodium channel subtype in action potential generation by neocortical pyramidal neurons. | 4.48e-06 | 3 | 43 | 2 | 29991598 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 20038812 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 28518218 | ||
| Pubmed | Renal tubular reabsorption of folate mediated by folate binding protein 1. | 4.48e-06 | 3 | 43 | 2 | 15703271 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 15694460 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 17928448 | ||
| Pubmed | Expression patterns of folate binding proteins one and two in the developing mouse embryo. | 4.48e-06 | 3 | 43 | 2 | 9973545 | |
| Pubmed | Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. | 4.48e-06 | 3 | 43 | 2 | 10508523 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 38514708 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 15302875 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 17537961 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 27122634 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 35031483 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 29578003 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 21156207 | ||
| Pubmed | Identification of two putative novel folate receptor genes in humans and mouse. | 8.94e-06 | 4 | 43 | 2 | 11111049 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 22260870 | ||
| Pubmed | Identification of G protein alpha subunit-palmitoylating enzyme. | 8.94e-06 | 4 | 43 | 2 | 19001095 | |
| Pubmed | Mutations in folate transporter genes and risk for human myelomeningocele. | 8.94e-06 | 4 | 43 | 2 | 28948692 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 20683905 | ||
| Pubmed | Palmitoylation regulates epidermal homeostasis and hair follicle differentiation. | 1.03e-05 | 34 | 43 | 3 | 19956733 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 24077057 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.49e-05 | 5 | 43 | 2 | 22875929 | |
| Pubmed | NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation. | 1.49e-05 | 5 | 43 | 2 | 38583156 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 1.85e-05 | 264 | 43 | 5 | 32814769 | |
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 16029194 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 25253725 | ||
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 2.23e-05 | 6 | 43 | 2 | 17513486 | |
| Pubmed | DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors. | 2.23e-05 | 6 | 43 | 2 | 22031296 | |
| Pubmed | Folate transport in mouse cumulus-oocyte complexes and preimplantation embryos. | 2.23e-05 | 6 | 43 | 2 | 23904512 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 3.12e-05 | 7 | 43 | 2 | 25818041 | |
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 23687301 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 22365888 | ||
| Pubmed | 5.86e-05 | 170 | 43 | 4 | 15057823 | ||
| Pubmed | 8.15e-05 | 11 | 43 | 2 | 24639464 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 9.24e-05 | 877 | 43 | 7 | 20211142 | |
| Pubmed | 9.49e-05 | 71 | 43 | 3 | 33541421 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 9.78e-05 | 12 | 43 | 2 | 30175250 | |
| Pubmed | 9.80e-05 | 608 | 43 | 6 | 16713569 | ||
| Pubmed | WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelination. | 1.15e-04 | 13 | 43 | 2 | 16723544 | |
| Pubmed | Regulation of the linear ubiquitination of STAT1 controls antiviral interferon signaling. | 1.35e-04 | 14 | 43 | 2 | 32123171 | |
| Pubmed | 2.26e-04 | 18 | 43 | 2 | 37321992 | ||
| Pubmed | The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. | 3.11e-04 | 106 | 43 | 3 | 31024071 | |
| Pubmed | DNA segments mapped by reciprocal use of microsatellite primers between mouse and rat. | 4.40e-04 | 25 | 43 | 2 | 8268655 | |
| Pubmed | Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. | 4.40e-04 | 25 | 43 | 2 | 23563309 | |
| Pubmed | 5.93e-04 | 29 | 43 | 2 | 19048631 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 6.02e-04 | 313 | 43 | 4 | 38270169 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 6.86e-04 | 139 | 43 | 3 | 25476789 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 6.86e-04 | 139 | 43 | 3 | 16985003 | |
| Pubmed | 7.87e-04 | 591 | 43 | 5 | 15231748 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 9.93e-04 | 358 | 43 | 4 | 32460013 | |
| Pubmed | 1.02e-03 | 38 | 43 | 2 | 28680062 | ||
| Pubmed | 1.11e-03 | 638 | 43 | 5 | 31182584 | ||
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | ZDHHC2 ZDHHC21 ZDHHC7 ZDHHC20 ZDHHC15 ZDHHC12 ZDHHC3 ZDHHC16 | 3.54e-17 | 24 | 33 | 8 | 76 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.15e-09 | 9 | 33 | 4 | 1203 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 4.20e-03 | 53 | 33 | 2 | 103 | |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 1.46e-05 | 190 | 43 | 5 | M8457 | |
| Drug | APETx1, Anthopleura elegantissima | 1.25e-07 | 6 | 43 | 3 | ctd:C475726 | |
| Drug | Piretanide [55837-27-9]; Up 200; 11uM; PC3; HT_HG-U133A | 1.76e-06 | 196 | 43 | 6 | 4490_UP | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 3.48e-06 | 2 | 43 | 2 | ctd:C502265 | |
| Drug | Zonisamide | 4.19e-06 | 17 | 43 | 3 | DB00909 | |
| Drug | Scorpion Venoms | 5.02e-06 | 18 | 43 | 3 | ctd:D012604 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 1.04e-05 | 3 | 43 | 2 | ctd:C561228 | |
| Drug | Multicide | 1.40e-05 | 25 | 43 | 3 | CID000024365 | |
| Drug | HC toxin from Helminthosporium carbonum; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.92e-05 | 175 | 43 | 5 | 909_UP | |
| Drug | Fospropofol | 2.09e-05 | 4 | 43 | 2 | DB06716 | |
| Drug | LY233053 | 2.09e-05 | 4 | 43 | 2 | CID000130475 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 2.09e-05 | 4 | 43 | 2 | ctd:C501880 | |
| Drug | Propofol | 2.09e-05 | 4 | 43 | 2 | DB00818 | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 2.79e-05 | 189 | 43 | 5 | 6649_DN | |
| Drug | Tolazamide [1156-19-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.08e-05 | 193 | 43 | 5 | 2842_UP | |
| Drug | alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 3.16e-05 | 194 | 43 | 5 | 4531_UP | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.32e-05 | 196 | 43 | 5 | 2240_UP | |
| Drug | Hydrocortisone base [50-23-7]; Down 200; 11uM; PC3; HT_HG-U133A | 3.32e-05 | 196 | 43 | 5 | 6684_DN | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A | 3.48e-05 | 198 | 43 | 5 | 3700_DN | |
| Drug | Riboflavine [83-88-5]; Up 200; 10.6uM; PC3; HT_HG-U133A | 3.56e-05 | 199 | 43 | 5 | 4485_UP | |
| Drug | benzocaine | 4.66e-05 | 37 | 43 | 3 | CID000002337 | |
| Drug | sipatrigine | 4.66e-05 | 37 | 43 | 3 | CID000060803 | |
| Drug | Tetrodotoxin | 5.90e-05 | 40 | 43 | 3 | ctd:D013779 | |
| Drug | TG12 | 7.27e-05 | 7 | 43 | 2 | CID011972112 | |
| Drug | fluorocyclobutane | 7.27e-05 | 7 | 43 | 2 | CID011051569 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 9.69e-05 | 8 | 43 | 2 | ctd:C489827 | |
| Drug | AC1NSN3X | 1.46e-04 | 54 | 43 | 3 | CID005366189 | |
| Drug | Bursin | 1.55e-04 | 10 | 43 | 2 | CID000194104 | |
| Drug | RH-3421 | 1.90e-04 | 11 | 43 | 2 | CID000108039 | |
| Drug | chloroacetylajmaline | 1.90e-04 | 11 | 43 | 2 | CID000038681 | |
| Drug | methylglucamine | 2.20e-04 | 62 | 43 | 3 | CID000004049 | |
| Drug | Ro 22-9194 | 2.27e-04 | 12 | 43 | 2 | CID000129209 | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.46e-04 | 162 | 43 | 4 | 7340_UP | |
| Drug | saxitoxin | 2.53e-04 | 65 | 43 | 3 | CID000037165 | |
| Drug | CID6432355 | 2.68e-04 | 13 | 43 | 2 | CID006432355 | |
| Drug | 20(S)-Propanaxidiol | 2.68e-04 | 13 | 43 | 2 | CID005317623 | |
| Drug | AC1LCJM3 | 2.68e-04 | 13 | 43 | 2 | CID000631640 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.88e-04 | 169 | 43 | 4 | 3868_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.88e-04 | 169 | 43 | 4 | 1793_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 2.95e-04 | 170 | 43 | 4 | 1014_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.08e-04 | 172 | 43 | 4 | 2330_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.08e-04 | 172 | 43 | 4 | 3979_UP | |
| Drug | SAHA; Up 200; 10uM; MCF7; HT_HG-U133A | 3.08e-04 | 172 | 43 | 4 | 5580_UP | |
| Drug | lorcainide | 3.13e-04 | 14 | 43 | 2 | CID000042883 | |
| Drug | octylguanidine | 3.13e-04 | 14 | 43 | 2 | CID000030621 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.15e-04 | 173 | 43 | 4 | 5625_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.22e-04 | 174 | 43 | 4 | 5260_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.22e-04 | 174 | 43 | 4 | 5572_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.29e-04 | 175 | 43 | 4 | 2835_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.29e-04 | 175 | 43 | 4 | 3243_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.29e-04 | 175 | 43 | 4 | 3428_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.29e-04 | 175 | 43 | 4 | 5417_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.37e-04 | 176 | 43 | 4 | 992_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.44e-04 | 177 | 43 | 4 | 4710_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.44e-04 | 177 | 43 | 4 | 6784_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 3.44e-04 | 177 | 43 | 4 | 1072_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.44e-04 | 177 | 43 | 4 | 3395_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 3.44e-04 | 177 | 43 | 4 | 5945_UP | |
| Drug | SAHA; Up 200; 10uM; MCF7; HT_HG-U133A | 3.44e-04 | 177 | 43 | 4 | 1645_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.44e-04 | 177 | 43 | 4 | 4768_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.51e-04 | 178 | 43 | 4 | 5693_UP | |
| Drug | trichostatin A ; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 3.51e-04 | 178 | 43 | 4 | 873_UP | |
| Drug | 2,3-dihydroxybenzaldehyde | 3.56e-04 | 73 | 43 | 3 | CID000090579 | |
| Drug | trimethyloxonium | 3.60e-04 | 15 | 43 | 2 | CID000093245 | |
| Drug | nonanol | 3.60e-04 | 15 | 43 | 2 | CID000008914 | |
| Drug | AC1L1W4O | 3.60e-04 | 15 | 43 | 2 | CID000036625 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.66e-04 | 180 | 43 | 4 | 7236_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.66e-04 | 180 | 43 | 4 | 2639_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.74e-04 | 181 | 43 | 4 | 7453_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.74e-04 | 181 | 43 | 4 | 1535_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.82e-04 | 182 | 43 | 4 | 3227_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 3.82e-04 | 182 | 43 | 4 | 6879_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.82e-04 | 182 | 43 | 4 | 5017_UP | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.90e-04 | 183 | 43 | 4 | 1074_UP | |
| Drug | scriptaid; Up 200; 10uM; MCF7; HT_HG-U133A | 3.98e-04 | 184 | 43 | 4 | 6901_UP | |
| Drug | scriptaid; Up 200; 10uM; PC3; HT_HG-U133A | 3.98e-04 | 184 | 43 | 4 | 6919_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 4.07e-04 | 185 | 43 | 4 | 1637_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 4.07e-04 | 185 | 43 | 4 | 5935_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 4.07e-04 | 185 | 43 | 4 | 6916_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A | 4.15e-04 | 186 | 43 | 4 | 1612_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 4.15e-04 | 186 | 43 | 4 | 6891_UP | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 4.23e-04 | 187 | 43 | 4 | 3240_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 4.23e-04 | 187 | 43 | 4 | 5976_UP | |
| Drug | wortmannin; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 4.41e-04 | 189 | 43 | 4 | 911_UP | |
| Drug | 5253409; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 4.50e-04 | 190 | 43 | 4 | 961_UP | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; PC3; HT_HG-U133A | 4.50e-04 | 190 | 43 | 4 | 7305_DN | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 4.59e-04 | 191 | 43 | 4 | 7397_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.59e-04 | 191 | 43 | 4 | 6020_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | 4.59e-04 | 191 | 43 | 4 | 4289_DN | |
| Drug | articaine | 4.65e-04 | 17 | 43 | 2 | CID000032169 | |
| Drug | lifarizine | 4.65e-04 | 17 | 43 | 2 | CID000071336 | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 4.68e-04 | 192 | 43 | 4 | 3188_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.68e-04 | 192 | 43 | 4 | 1059_UP | |
| Drug | rosiglitazone; Up 200; 10uM; HL60; HT_HG-U133A | 4.68e-04 | 192 | 43 | 4 | 1174_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A | 4.68e-04 | 192 | 43 | 4 | 5206_UP | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 4.77e-04 | 193 | 43 | 4 | 3197_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.86e-04 | 194 | 43 | 4 | 7214_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 4.86e-04 | 194 | 43 | 4 | 4159_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.86e-04 | 194 | 43 | 4 | 1001_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A | 4.86e-04 | 194 | 43 | 4 | 4758_DN | |
| Drug | Propantheline bromide [50-34-0]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.86e-04 | 194 | 43 | 4 | 4798_UP | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 6.69e-10 | 10 | 41 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 6.69e-10 | 10 | 41 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.57e-09 | 12 | 41 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Mental Retardation, Psychosocial | 1.41e-06 | 139 | 41 | 5 | C0025363 | |
| Disease | Profound Mental Retardation | 1.41e-06 | 139 | 41 | 5 | C0020796 | |
| Disease | Mental deficiency | 1.41e-06 | 139 | 41 | 5 | C0917816 | |
| Disease | syndrome (implicated_via_orthology) | 2.00e-06 | 18 | 41 | 3 | DOID:225 (implicated_via_orthology) | |
| Disease | B Virus Infection | 5.65e-06 | 3 | 41 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 5.65e-06 | 3 | 41 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 5.65e-06 | 3 | 41 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 5.65e-06 | 3 | 41 | 2 | C0019372 | |
| Disease | Epilepsy | 1.61e-05 | 109 | 41 | 4 | C0014544 | |
| Disease | Familial benign neonatal epilepsy | 2.82e-05 | 6 | 41 | 2 | C0220669 | |
| Disease | Intellectual Disability | 3.35e-05 | 447 | 41 | 6 | C3714756 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 6.74e-05 | 9 | 41 | 2 | C3502809 | |
| Disease | epilepsy (implicated_via_orthology) | 7.75e-05 | 163 | 41 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 1.23e-04 | 12 | 41 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.46e-04 | 13 | 41 | 2 | C0751122 | |
| Disease | Epilepsy, Cryptogenic | 2.04e-04 | 82 | 41 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 2.04e-04 | 82 | 41 | 3 | C0751111 | |
| Disease | Aura | 2.04e-04 | 82 | 41 | 3 | C0236018 | |
| Disease | anxiety disorder (implicated_via_orthology) | 4.28e-04 | 22 | 41 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 4.68e-04 | 23 | 41 | 2 | C1708353 | |
| Disease | malignant astrocytoma (is_marker_for) | 4.68e-04 | 23 | 41 | 2 | DOID:3069 (is_marker_for) | |
| Disease | lung small cell carcinoma (is_implicated_in) | 6.96e-04 | 28 | 41 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 1.22e-03 | 37 | 41 | 2 | EFO_0007645, EFO_0009458 | |
| Disease | Craniofacial Abnormalities | 1.33e-03 | 156 | 41 | 3 | C0376634 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CTHFLWPMCIGEVAH | 31 | Q6ZUV0 | |
| RALHQHCACKMHPQW | 1646 | Q5JWR5 | |
| HCACKMHPQWIGLIT | 1651 | Q5JWR5 | |
| KGENEWLHDHCMQVG | 136 | P55040 | |
| EFLPCHIMDQHWKFC | 1851 | Q8N7Z5 | |
| EWVMGGHCFLDRCNH | 426 | Q9C0I1 | |
| CRHHLCEPDMKLVWP | 356 | Q96T76 | |
| WDHCGKMEPTCKRHF | 86 | P41439 | |
| HGECIPAHWRCDKRN | 1076 | P98164 | |
| KPHQVDGVQFMWDCC | 1561 | P46100 | |
| HICEITWECLQPMKG | 1061 | Q9Y2H6 | |
| CPISLHELMIHCWKK | 491 | P06241 | |
| MGCPHALHQLMLDCW | 861 | P29322 | |
| MPDWHHHCQVIMRSC | 361 | Q9H9V9 | |
| MQKARHCGHCPEEWI | 111 | O43908 | |
| WNHCGEMAPACKRHF | 86 | P15328 | |
| VLVMFHAPWCGHCKK | 296 | Q14554 | |
| FEEHVESHWKVCPMC | 746 | Q86VP1 | |
| CKIALDCNLPRWHMH | 731 | P35499 | |
| HMIDGRWCDCKLPNS | 166 | Q13148 | |
| PCMHLFHQLCVDQWL | 311 | Q6ZSG1 | |
| VCKINDDCTLPRWHM | 896 | Q15858 | |
| GRHMLKDDWTVCPHC | 1281 | Q8NEZ3 | |
| HLPWHCAACAMLNEP | 301 | Q96EP0 | |
| KMWGLAEFHCPKCRH | 146 | Q9NUL5 | |
| DSCILKMDHHCPWVN | 146 | Q5W0Z9 | |
| KMDHHCPWVNNCVGF | 151 | Q5W0Z9 | |
| CKRCIRKMDHHCPWV | 146 | Q9NYG2 | |
| RKMDHHCPWVNNCVG | 151 | Q9NYG2 | |
| HDNPWDCTCDIVGMK | 561 | O94991 | |
| VCKISNDCELPRWHM | 911 | Q99250 | |
| PLEWHCKQMDHFVGL | 2366 | P21359 | |
| NHALHMPRGECEESW | 281 | O95685 | |
| CKINQDCELPRWHMH | 906 | Q9UQD0 | |
| RCVLKMDHHCPWLNN | 176 | Q969W1 | |
| HCVRRMDHHCPWINN | 111 | Q8IVQ6 | |
| MDHHCPWINNCVGED | 116 | Q8IVQ6 | |
| VQWRGEMKHFCDQHC | 781 | Q9UBW7 | |
| IWHLGPEITNCMKQH | 741 | O43379 | |
| MGLCGLLERCWLHHD | 1 | Q9UL36 | |
| RCIRKMDHHCPWVNN | 151 | Q9NXF8 | |
| MDHHCPWVNNCVGEK | 156 | Q9NXF8 | |
| CDKCILKMDHHCPWV | 146 | Q9UIJ5 | |
| LKMDHHCPWVNNCVG | 151 | Q9UIJ5 | |
| HCPWMENCVGERNHP | 126 | Q96GR4 | |
| IHIGHKQFMCQWCGK | 406 | Q9Y2D9 | |
| CWCVDAQGKEMHGTR | 336 | P01266 | |
| CWQAEHCGEVHNKDM | 491 | P35125 | |
| HCGEVHNKDMSWPEE | 496 | P35125 | |
| CVLKMDHHCPWVNNC | 151 | Q96MV8 | |
| IQCRHCERWMHAGCE | 1521 | O14686 | |
| RCWKDHCMDKHNGTD | 371 | Q92802 |